Tag:
immatics
Latest Headlines
Latest Headlines
Immatics banks $70M to fund pivotal cancer vax trial
Underscoring the general excitement about the market potential of therapeutic cancer vaccines, Germany's immatics has gathered more than $70 million from its Series C investors to back the
